CLASS II Device recall · Reported 5 Apr 2017 · FDA Enforcement Report

Legionella IFA Substrate Slide (IF0951) intended recalled

Focus Diagnostics is recalling Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and, distributed in California, New Jersey, Virginia. The recall was initiated on 15 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesIF0951: 10816101020055, lot numbers 29428, 31871
Quantity recalled1,400 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1686-2017
FDA event ID
76619
Recalling firm
Focus Diagnostics, Cypress, CA
Classification
Class II
Status
Terminated
Recall initiated
15 Feb 2017
FDA classified
27 Mar 2017
Reported
5 Apr 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Feb 2017Recall initiated by company
27 Mar 2017Classified by FDA+40 days
5 Apr 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.

Product as listed by the FDA

Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and semi-quantitating human serum antibodies to Legionella pneumophila.

Where it was distributed

Product was distributed to three testing laboratories in California, New Jersey and Virginia

CaliforniaNew JerseyVirginia

Questions about this recall

Is Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and recalled?

Yes. Focus Diagnostics recalled Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and on 15 Feb 2017. The recall is Class II and its status is Terminated. Recall number Z-1686-2017.

Why was it recalled?

After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.

Which lots are affected?

IF0951: 10816101020055, lot numbers 29428, 31871

Where was it sold?

Product was distributed to three testing laboratories in California, New Jersey and Virginia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Focus Diagnostics

All 11

Other Other Medical Devices recalls

All 13,778